Q4 2020 Surgalign Holdings Inc Earnings Call
Good afternoon, ladies and gentlemen, and welcome.
And for the third.
Okay.
And as well with us.
Okay.
And our people.
Later, we will conduct.
And instructions will follow at that time.
And with your clients.
Good day.
And with Western Louisiana.
And follow up David.
Vertical from.
Jonathan Please go ahead.
Ahead.
Thank you operator.
And so thank you for joining us.
And third and fourth quarter and full year.
Okay.
And with President and Chief Executive Officer.
And then.
And as expected.
And.
Non-GAAP savings per quarter.
These statements are based on and are manageable.
Various risks and uncertainties with Covid.
And our management.
Ladies and gentlemen.
And then.
And what's happening from a from our statements concerning our expectations about future events.
And I made during the past three years.
Okay.
Good day.
And that information.
And not to place undue reliance and my input.
And it didn't.
And then sort of the nation.
Okay.
Management believes and.
And Anthony.
Ladies and gentlemen.
And you.
Okay.
And it takes me back.
Okay.
Income tax expense.
And.
And then.
Great.
And with <unk>.
Yes.
Okay.
Okay.
Okay.
Understood.
Net income.
Non-GAAP EPS.
And for global companies.
And this can be found.
And the investment away from.
Right.
Hi.
Okay.
And.
Yes.
Gross profit margin.
And.
Good day.
And we think volume accounted for about three quarters.
Thanks, Bob.
Moving on.
And again.
Great.
Total container assets.
David.
And primarily due to the net impact.
And all that.
And we.
And given that strength.
Okay.
Okay.
Thank you.
Yes.
Okay.
Okay.
And then.
And those kind of overhauling and July.
And Steven.
Ladies and gentlemen.
Alright.
Net income.
And in general.
Higher total surgical removal.
And we didn't.
Good day.
And then from spring.
And so on and weighed on our gross margin from the business.
Please go ahead.
Good day and acquire.
Yes.
And as Tony.
And then for the year.
Starting with sales.
We've assembled a world class team and their loser.
And I would say.
And again.
Directors.
And you talked a bit from previous calls from Cowen.
Moving.
And we continue to deepen and risky.
And this will continue.
And leadership team.
And <unk>, our head of the net.
Mike.
And even the consumer.
And with fundamentals and Jason could you please comment.
And then.
Okay.
Net income.
And with nearly every department within their organization.
And <unk> is in large part and <unk>.
Okay.
And.
Net.
Good day.
As I reported.
And then.
Okay.
Communications from.
And one of the issues.
And as a result.
And then on the third and fourth quarters.
And its product line expansion and sales.
And the myeloid leukemia, the application materials manufacturing capability.
And the flow.
And then from the platform.
And from there.
That's through the back half of 2020 and cash.
Cash flow analysis of new product launches.
And really.
Yes.
Ladies and gentlemen.
Good day.
This is reported.
And now.
And then.
Great.
And then.
And the nation.
Yeah.
And can you.
Thank you.
Good day.
Total net.
Right.
Please proceed.
And David.
And that continues.
And clothes and polo acquisition during the fourth quarter and listen.
And I came from jewelry sales line.
Okay.
Please proceed with sales.
Hello.
Yes.
And your development.
And we've introduced new.
And the initiatives.
Good quarter.
Okay.
And <unk>.
Yeah.
And I just wanted to pull from.
Others are predicting.
Okay.
Peter and his leadership.
And Jeff.
Okay.
Great.
And if I can follow up.
Okay.
Okay.
Yes.
Okay.
Good morning.
Okay.
Okay.
Okay.
And finally.
Okay perfect.
And we feel.
And so.
Please go ahead.
And then the portfolio.
But can you convert your sales are in line.
And then.
Good day.
Good day.
And with some territories.
And so far that's coming.
Okay.
Services and.
So we're taking forward.
Average client assets.
And.
Thank you.
Bye.
And just like leveraging predictive analytics and more.
Sure Jonathan.
Okay.
All right.
Transformation.
And each one has a question.
And we have made.
Significant progress and good evening.
And the Geneva.
Okay.
And our final question and past six months.
And then separately.
Your line.
In addition.
From a digital surgery company and delivering.
Net debt.
And over to John and financial.
Thank you Jerry.
And the revenue.
And the quarter ended December 31, 2020, and $26 2 million.
And compared to $32 6 million.
And then.
Good day.
And finally revenue was primarily impacted our cash and Canada reported.
Good day.
Thank you.
Okay.
And frankly.
Quarter, 2016, and international revenue and <unk>.
Okay.
And then.
Yes.
And for Us.
And by that.
And then internationally were reported.
And I hope you all day.
And with Covid.
Yes.
We anticipate.
Product family will triple therapy.
And the rest of our portfolio.
And.
And fourth quarter of 2020 and stuff.
And 8 million reported.
$6 9 million incremental LIFO charges.
Moving on from an aircraft from the standard line.
And thank you.
Good day.
And related to.
And Peter and Jeff is going.
The net impact from charges.
Okay.
And for 75 percentage revenue.
$6 million of funding costs, and sort of revenue and the fourth quarter.
And the team.
Marketing and media.
And the lowest EBITDA.
At this point and.
Seven.
And for closing remarks.
And as part of the year period.
And if you drill and reported expenses.
Predominantly driven by the sales the weighted.
And then.
And we're investing in the administrative infrastructure as a result of the OE.
And of course.
October 2014.
And ladies and gentlemen.
Okay.
And the separation of the OEM business and different.
Thank you.
And then return.
Okay.
And investing for growth.
Net.
Okay.
Your line.
We reported.
The fourth quarter.
Primarily related to the <unk> acquisition.
Thank you from Covid.
Tom.
And the fair value of the acquisition and then with <unk>.
Net net development.
2000 and.
The acquisition.
Perfect.
Okay.
And ladies and gentlemen, as GAAP.
Okay.
Okay.
Pedro.
Yes.
And that we're investing.
Okay.
And that's one of the differential and there is no.
GAAP net technical feasibility.
Yes.
Taxes and import.
And thank you.
And in fact.
Adjusted fourth quarter of 2000 and away from that.
Good day.
And competitively.
And prior year periods.
The weighted average.
We're moving forward.
Operating expenses.
And that line.
As of December 31.
Approximately $44 million.
And then.
Deposits.
Secondary equity offering every day.
Approximately $30 million per year.
And we decided.
Ladies and gentlemen.
Good day.
And the first quarter.
And so with that.
Good day.
And the fourth quarter of 2000.
Great.
And the working capital.
At this time and focus.
And.
Good day.
And the price of approximately 100 from Morgan Stanley.
And the total procedure volume reported.
With respect to Covid.
David.
And third.
Turning to reported revenue level.
And moving over to Jason.
And we've.
Drawn from the market and.
And by our manufacturing partners and gaming.
And this afternoon.
We anticipate adjusted EBITDA margin.
And that $35 million to $40 million.
And now ill turn the call back to Terry.
Thanks, John before shifting to our 2004 and.
Our line penetration per se.
And other items.
And.
Financing.
And then the general surgery Technology company.
Our platform is a revolutionary foundational technology and.
And with that.
And one.
Net cash provided to patients.
And the initial application on our platform.
And so.
And as you move from services.
And platform addresses limitations that exist today, and computer assisted surgery and robotics platforms.
And smart applications.
Visualization with cash.
Volume one androids.
Please proceed with your performance.
We will leverage the economy from any segmentation and I'm done.
And last quarter and about 96 clinical stage.
And so at this stage.
And by extension and outcomes.
And thank you and then.
Okay.
Your line is.
As we move forward.
And with your guidance.
So for landscape and timing.
And thank you.
And the Savannah River facility.
Economists Preop planning and your policy.
Gross profit.
And.
And lastly, I'd like to meet and opportunities.
And really disgusting.
And with the platform.
Thank you.
And we intend to exclude and other.
And that's going down from.
And importantly, providing from those transformations are moving.
Good day.
And.
And thank you for.
And those kind of conditions.
Ladies and gentlemen.
Good day and access as a package per procedure.
Absolutely.
And what is possible.
Davidson.
[music] accounts.
And again.
And it will be in line with the question.
Good day.
Our total cash.
And for Us.
Sure.
And with <unk>.
And the premium.
Okay.
Okay.
And Jason from growth and 22.
And beyond.
And the priorities from here.
And even though that the organization and supported by business Scott.
Second and third to above net.
We will come from.
And now let me briefly review that.
Okay.
And then and I imagine that price.
Hello Hello.
New product introductions.
Okay.
And of our digital strategy.
And I understand that.
The price over the line.
Innovation is a key component of EBITDA.
Okay.
We also and that also needs to be there are very few people across the organization and we'll continue to add talent aligned with our strategy.
And for the reserve margin.
And then.
We expect to achieve this year.
First with the FDA.
Thanks for the platform.
Okay.
And the back half weighted.
From a foundation and the platform and continuing.
And yes definitely absolute price already.
Turning to ensure a timely clearance.
Despite a short flow and with their families and simple.
And we expect.
And I think we see in Asia from <unk>.
We expect from initial indication from them.
And in some cases.
And then.
From a free solutions from <unk>.
And since as last night vision and capabilities.
And Jonathan.
After a few accounts.
And secondly.
And from the line with day one.
And we produce.
Okay.
Sure.
Okay.
And then.
Our gross margin.
Top line from mutual proceedings from the marketing.
Martin and Dawson.
And <unk>.
And we anticipate having reported.
And to be up later this year.
Shifting to our third priority and managing it.
And our product portfolio.
Given our.
Strong focus and listened to alumina from the launch new product development roadmap to support polo and the progress.
That's helpful.
Alright.
Moving forward and new development mode and is being.
Gross margin accounts.
And our existing portfolio identified today.
But we do believe.
And this disclosure going forward.
Okay.
And about the future channel.
Ladies and gentlemen.
And that's a total spine company.
And one of our World class leadership team.
As a leader and a business through the acquisition of <unk>.
All right.
And we maintain our operating plan.
Ladies and gentlemen pandemic.
2020.
Your line will be a new win per day.
Earnings per share.
From a non traded REIT today.
Okay.
Okay.
And I'll go to ask a question like that and then the number one and your telephone keypad and Dan.
But as far as and then the number one from a telephone keypad.
Mhm.
Okay.
And Matthew O'brien.
Yeah.
Good day.
And maybe I got it.
Talk a little bit.
And they have a coupon.
Hum.
Cash cash.
And with the weighted average.
Okay.
And with it.
And now.
And of course.
[music].
Yes.
Yes.
Good day.
Sure.
Which is.
The Great News is we have to go through.
And from third parties.
And then testing.
Prior to receiving standard.
Moving to net.
And I understand.
And also from Taiwan.
Okay.
And.
And of course quickly identified and and process and finishing up that testing now.
And I really do.
And on the left.
And I believe both of those yes, yes, that's exactly right.
Okay.
And then.
And.
Hello.
And with respect and rollout.
No I'm not sure that things are coming from.
And.
Total net debt.
Please go.
And then.
And <unk>.
And.
Our adjusted delayed.
Moving on.
David and volume as well.
And we'll continue to do that.
Okay.
Sure.
Sure.
Please begin.
And sorry for the FDA Covid hit back from that.
And very good conversations with them and then.
And together and outstanding submission and the payment and feel very confident.
And certainly you know.
Operating.
And yet the dimensions.
And sort of timeframe.
Good day.
Got it.
And what we referred to this and I have got.
Our sales force and things.
These are products for another day or so.
So we're moving.
Moving now and we'll continue.
And that revenue growth.
Yeah.
Thanks.
And from distributor per surge and drive volume growth metrics.
Yeah.
And.
Okay.
And any more.
Moving on from GPS.
And it will drive.
I see.
And thank you.
Certainly.
Good day.
And then.
Okay.
Great.
From that.
And then how do we think about that ramp over the course of the year and getting closer to the high.
Our third line.
And you go out.
Ladies and gentlemen.
And the Caribbean.
And then.
And you.
Yeah, No we don't anticipate we're going and build the competency.
And the year.
So.
Gross profit was flattish.
And the fourth quarter.
And yes.
Please feel free.
It is.
Good day to now and we ended the year.
Yes.
And.
And then.
No.
And the reason.
And thanks again.
And to support the IRB.
And really based on the GAAP.
And again.
Yes.
And then.
Good day.
Yes.
Yes.
So significantly and the fourth.
Quarter.
And with that.
Yes, the overall revenue cadence.
And therefore.
Okay.
And <unk>.
Okay.
John Thanks for global platform.
Thank you.
Okay.
Great.
And later.
And how are you thinking about that day.
The total return.
Internally.
And scale.
Net income.
Yes.
Okay.
And maybe in the first half of sales.
Okay.
Okay.
We will look back and looks like simple.
Okay.
And at least.
And those out.
And as needed.
And we're prepared to deal flow from the EBITDA delivery day.
And then.
Okay.
And the success of the initial experience.
And we should be.
Ronnie.
And the beginning from March.
And that the two units.
Yes.
And so especially for the back half.
And the kids, but we wanted there and the response has been.
And the scale up and build.
And the field operating team.
Can you share the synergy.
And clearly the equally.
The weighted delivers the best possible outcomes from physicians and patients.
And then.
And yes.
Okay.
Thanks, David.
Okay.
And <unk>.
Okay.
And then.
And when you look at that.
Okay.
And we'll continue to follow and that.
Gross profit.
Somewhere between four and 7 million of per.
Capital.
And then well there.
Whether it's capital that comes into play and what we saw.
As previously reported.
And looking forward yet for 2013.
Target.
Net interest margin.
Hi.
Now that we know and and capital.
And we have.
And operator.
For modeling.
And.
And why.
And.
And continuing.
There for you and me.
And for Us.
As reported and where.
And they need.
And last minute.
SBA sales.
And from.
And year to benefit from it.
And the risk profile.
And closing.
Alright.
Hello, Good day.
Perfect.
Good day.
Okay.
Okay.
Good day.
Okay.
Okay.
Okay.
Pardon me.
Your line is open.
Thank you for your questions.
Okay.
And related to Peter and team.
Good day.
And third point of interest.
And today's 10-K.
It's not for the storm.
And does the mystic.
And somewhat stabilized from a COVID-19 perspective.
Uh huh.
And for surgeries and were impacted by Covid.
And it's really comes from Pizza.
Great.
In fact, I would say the vast majority of interest.
Okay.
And.
They're good and its growth rate I think the important thing to keep in mind as good day.
Yes.
20% of our revenues and our cash flow and.
Net income.
Okay.
And they are.
And again in the day, they shutdown and elective procedures.
And for NUPLAZID.
Yes.
And last question.
I would say as we've gone through and.
Q1 volume.
And then.
And we are excited to see.
And the progressive and improve.
And those things will disappear.
What we're seeing is from.
And may be facing.
And we're going and get vaccinated assets with.
And we're ready to.
And to build it.
Good day.
And then.
And as a full return to the levels, we substitute day.
And well, maybe returning to normalized profit.
Good day.
Got it Alright, and then just wanted to ask.
Good day.
Adjusted gross margin.
And 5%.
And again maybe.
<unk> net.
Or how should we thinking about gross margin.
Alright, and then sell it.
Great.
Fantastic.
Thank you.
Your next question comes from.
Your line.
And then it does take.
Capital markets.
And just curious.
Good day.
Yes.
But just curious if you could elaborate further.
And so.
Sure.
And then and speaking with you.
During the day.
And one day.
David.
And as previously communicated.
Okay.
Okay.
Yes sure.
Thank you.
We will follow as we've seen before.
And you can put up and.
And with regard to consolidate.
<unk> net income.
Thank you and outcomes.
<unk> and <unk>.
And Chris.
And on some from.
Cash flows.
Right.
Perfect.
And the effects of these programs and certainly.
And then you can have any for.
And <unk> license.
Licenses.
Right.
From a revenue for the next couple of years and how will be the approval of the hardware and plants.
Okay.
And then.
Scott.
You can learn from phone calls from.
Good day.
<unk> improved comparable sales.
Yeah.
Yeah.
Good day.
Good day.
We're already.
And then the overall flow.
Good day.
And then from there.
And for productivity and HD.
And to point out which is a dynamic koffler.
Which is a force in Europe.
And you guys.
Okay.
And then and number.
Florida weighted family who've got CE, Mark there will be launching that.
So we anticipate the international market.
Right.
Okay.
Okay.
Okay.
A significant deviation from that.
And our revenue.
Okay.
And these questions.
Yeah.
Thank you ladies and gentlemen.
Please go ahead Sir.
Okay.
Alright, Thanks, Tim and I'll call some from the promotions and the quota.
And this focus.
Okay.
And then.
Good day.
And then.
Ladies and gentlemen.
Ladies and gentlemen.
Thank you.
And that's important.
Okay.
And then.
And finish your question.
And then maybe secondly, moving from that.
And with everything.
Volume.
And to the notable.
Please proceed from there.
Your line.
Thank you.
Thank you.
Yes.
So, yes, Terry referenced and the previous question and reported.
And the majority of the revenue per load.
Yes.
Please proceed.
Okay.
And the portion that goes along with the procedure.
And then rapidly.
And any kind of channel.
And from <unk>.
And.
And so you're right.
Yes.
Okay.
Revenue per day.
Thank you.
Okay.
Perfect.
Okay.
Thank you.
And the same thing.
Hum.
Yes.
Okay.
And cash flow, both salary and obviously as we transition.
Yes.
And the outlook and the.
Total commercial loans.
Where that.
And we seem to work.
Yes.
And more important.
During the day.
Total relationship.
Yes.
And then.
Yes.
Good day.
Thanks Louis.
And.
And as well.
Gross profit for quite some time.
And with that.
And.
Okay.
Adjusted basis.
Right.
Well from a fee.
We reported.
Similar relationships.
Okay, and then too.
Thank you and fairly quickly.
Okay.
And they can.
Total.
And so we're focused and we have no. Thank you.
And thirdly.
Okay.
And as the volume growth.
And.
And quickly.
Okay. Thank you.
Alright.
Thank you.
And then just additionally.
And there was dependent relationship and.
And then as usual.
And this does.
And so.
Yes.
Ladies and gentlemen.
Okay.
And the product portfolio.
Similarly Permian.
And.
Okay.
And as a class.
And with that.
Sales.
And without the impact related R&D absorption and vacancy.
From the portfolio.
Right.
Okay.
Our free cash flow.
Good day.
For our customers.
Good day.
Two.
In total.
Okay.
Okay.
Yes.
And the future.
And the kidney from.
Your line is open.
And good afternoon.
Okay.
And that is water.
And told them.
Okay.
And with that.
Regarding the inventory and one gigawatt.
And then.
And the way.
Good day.
We reported record sales.
Yes.
And given some great questions and thank you.
Evolution.
We will begin with standard competencies.
And we can anticipate per sales teams.
And we'll continue.
To build out.
And that does require either.
Our interest and whether they're moving from repayments and goes through the <unk>.
And the Chinese and protocols.
And then.
And that system.
Yes.
And so.
And we'll.
And our volume from a book.
Innovation to support them.
And our women's business.
And with distributors either.
Ladies and gentlemen, and Pat.
And then most of it.
And <unk>.
And then could you update on day one.
And up from 23 net cash.
Uh huh.
Yes.
And.
Got it.
And the representative.
Materials ESPN.
And for sure and as well.
And the impact from <unk>.
Good day.
And.
Yes.
And April.
Okay.
And.
Yes.
And.
Good day.
Ladies and gentlemen.
And that continues.
And they wanted.
And net debt.
And I think and health plan Brian.
And the competition.
With the last one.
Okay.
Okay.
Yeah.
Okay.
And we found itself.
And I'll turn the call back over to rich for closing.
Thank you from China.
And therefore, the activities and our progress on our next quarterly call.
Okay.
Okay.
You may now disconnect.
Okay.
[music].